Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Healthpoint
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Provide written informed consent, which will consist of reading, signing, and dating the informed consent document after the Investigator, sub-Investigator or other designated study staff member has explained the study procedures, risks, and contact information.
Subjects 18 years of age or older of either sex with a history of diabetes mellitus (Type 1 or 2) requiring medication (insulin and/or oral/injectable) to control blood glucose levels.
A non-healing, Wagner grade 1 or 2, neuropathic diabetic foot ulcer.
Willing and able to make all required study visits.
Able to follow instructions.
An ulcer present on any part of the plantar surface of the foot, which is 0.5 cm2 to 10 cm2 (inclusive), as measured at the Screening Visit prior to debridement, with a duration ≥ 6 weeks (documented in the patient's history or by patient report of onset) but not more than 12 months.
Separation of at least 5 cm (wound edge to wound edge) if ≥ 2 wounds are present.
Adequate arterial blood flow as evidenced by an ankle brachial index (ABI) of \> 0.7 and ≤ 1.1. If the ABI is greater than 1.1, then a toe pressure of \> 40 mmHg OR a transcutaneous oxygen pressure (TcPO2) ≥ 40 mmHg must be present. Either toe pressure or TcPO2 is also acceptable in lieu of ABI, but if both are obtained, each must meet its respective cutoff.
Alternatively, a Doppler waveform consistent with adequate flow to the region of the foot with the target ulcer (biphasic or triphasic waveforms) is acceptable (test result must be included in the source document).
Target ulcer is not infected based on clinical assessment.
Able to perform any required dressing changes at home or have a caregiver who can perform the dressing changes.
Willing to use an appropriate off-loading device to keep weight off of foot ulcers.
Blood counts and blood chemistry values as follows:
* Alanine aminotransferase (ALT) ≤ 3x upper limit of normal
* Aspartate aminotransferase (AST) ≤ 3x upper limit of normal
* Serum albumin ≥ 2.0 g/dL •Pre-albumin levels of ≥ 10 mg/dL
